Resistant malaria in a neonate

Indian Pediatrics

Volumn 39, Issue 6, 2002, Pages 585-588

  Patel, Archana B ^a   Belsare, Hrishikesh S ^a  

^a Indira Gandhi Medical College ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; HALOFANTRINE; MEFLOQUINE; QUININE;

ANTIMALARIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; DRUG RESISTANCE; EXPERIENCE; FEMALE; HUMAN; INFANT; MALARIA; NEWBORN PERIOD; NEWBORN SEPSIS; PLASMODIUM FALCIPARUM; RETICULOCYTE COUNT;

ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALARIA, FALCIPARUM; MEFLOQUINE; QUININE; RISK ASSESSMENT; SESQUITERPENES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036088795     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bruce Chwatt LJ. Chemotherapy of Malaria. WHO Technical Report Series No. 27, Geneva, World Health Organization, Geneva 1986.
2. World Health Organization. Assesment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL96.1077. Geneva, World Health Organization, 1996; P33.
3. Airede AI. Congenital malaria with chloroquine resistance. Ann Trop Pediatr 1991; 11: 267-269.
4. Looareeesuwant S, Vivaran C, Vanijanonta S, Wilairatana P, Pitisuttithum P, Andrial M. Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: Two-and three-day regimens. Am J Trop Med Hyg 1996; 54: 210-213.
5. Olanrewaju WI. Malaria in the neonate: Report of two cases. West Afr J Med 1999; 18: 139-140.
6. Price R, Luxemberger C, van Vugt M, Nosten F, Kham A, Simpson J, et al. Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitemic falciparum malaria. Trans R Trop Med Hyg 1998; 92: 207-211.
7. Ibhanesebhor SE, Okolo AA. Malaria parasitemia in neonates with predisposing risk factors for neonatal sepsis: Report of six cases. Ann Trop Pediatr 1992; 12: 297-302.
8. Ibhanesebhor SE. Clinical characteristics of neonatal malaria. J Trop Pediatr 1995; 41: 330-333.
9. Price RN. Artemisinin drugs: Novel antimalarial agents. Expert Opin Investig Drugs 2000; 9: 1815-1827.
10. ter Kuile F; Nosten Fr, Luxemberger C, Kyle D, Teja-Isavathram P, Phaipun L, et al. Mefloquine treatment of acute falciparum malaria: A prospective study of non-serious adverse effects in 3673 patients. Bull WHO 1995; 73: 631-642.
11. Price R, vanVugt M, Phaiphun L, Luxembergur C, Simpson J, Mcgready R, et al. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives. Am J Trop Med Hyg 1999; 547-555.
12. Compos SB, Rouch LH, Seguro AC. Effects of sodium artesunate, a new antimalarial drug, on renal function. Kidney Int 2001; 59: 1044-1051.
13. Genovese RF, Newman DB, Brewer TG. Behavioral and neural toxicity of the artemisinin antimalarial, artether, but not artesunate and artelinate, in rats. Pharmacol Biochem Behav 2000; 67: 37-44.